Price Models for Multi-indication Drugs: A Systematic Review
Sign Up to like & getrecommendations! Published in 2019 at "Applied Health Economics and Health Policy"
DOI: 10.1007/s40258-019-00517-z
Abstract: Background Marketing of new and existing drugs with new indications used alone or in combination is increasing. Objective To identify the advantages and disadvantages of indication-based pricing (IBP) systems for such drugs from the standpoint… read more here.
Keywords: price models; ibp systems; systematic review; price ... See more keywords